Immune monitoring in a phase 1 trial of a PSA DNA vaccine in patients with hormone-refractory prostate cancer. [electronic resource]
Producer: 20051017Description: 389-95 p. digitalISSN:- 1524-9557
- Antigen Presentation -- immunology
- Antigens, CD -- analysis
- Antineoplastic Agents, Hormonal -- pharmacology
- CD8-Positive T-Lymphocytes -- immunology
- Coculture Techniques
- Dendritic Cells -- immunology
- Drug Resistance, Neoplasm
- Humans
- Immunity, Cellular -- immunology
- Immunophenotyping
- Interferon-gamma -- metabolism
- Interleukin-10 -- metabolism
- Interleukins -- metabolism
- Lymphocyte Activation -- immunology
- Male
- Monitoring, Immunologic
- Peptide Fragments -- immunology
- Prostate-Specific Antigen -- genetics
- Prostatic Neoplasms -- drug therapy
- T-Lymphocytes -- immunology
- Vaccines, DNA -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.